DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,125,000 | -83.7% | 100,000 | -83.3% | 0.00% | -87.5% |
| Q1 2023 | $6,912,000 | +49.1% | 600,000 | +50.0% | 0.02% | +45.5% |
| Q4 2022 | $4,636,000 | -18.9% | 400,000 | -11.1% | 0.01% | -21.4% |
| Q3 2022 | $5,715,000 | +45.9% | 450,000 | -21.1% | 0.01% | +55.6% |
| Q2 2022 | $3,916,000 | -45.8% | 570,000 | -24.0% | 0.01% | -35.7% |
| Q1 2022 | $7,230,000 | +508.1% | 750,000 | +650.0% | 0.01% | +600.0% |
| Q4 2021 | $1,189,000 | +46.4% | 100,000 | +100.0% | 0.00% | 0.0% |
| Q3 2021 | $812,000 | -61.4% | 50,000 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $2,104,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |